McCune-Albright Syndrome (MAS)
Showing 1 - 25 of >10,000
Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome
Recruiting
- McCune-Albright Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Fibrous Dysplasia, McCune Albright Syndrome Trial in Leiden (Denosumab 120 Mg/1.7 Ml Inj, Placebo)
Recruiting
- Fibrous Dysplasia
- McCune Albright Syndrome
- Denosumab 120 Mg/1.7 Ml Inj
- Placebo
-
Leiden, NetherlandsLeiden University Medical Center
Jul 20, 2023
Fibrous Dysplasia, McCune Albright Syndrome, Mazabraud Syndrome Trial in Grandville
Recruiting
- Fibrous Dysplasia
- +2 more
-
Grandville, MichiganFDMASRegistry.org
Aug 16, 2021
Fibrous Dysplasia/McCune-Albright Syndrome Trial in Boston (MRI-based Neuroimaging, Non-contrast MRI, 18F-FDG-PET/CT)
Enrolling by invitation
- Fibrous Dysplasia/McCune-Albright Syndrome
- MRI-based Neuroimaging
- +3 more
-
Boston, MassachusettsBoston Children's Hospital
Sep 1, 2021
Fibrous Dysplasia of Bone.
Completed
- Fibrous Dysplasia of Bone
- McCune Albright Syndrome
- Evaluation and analysis of clinical data
-
Lyon, Francerheumatology department, hopital Edouard Herriot
Jun 16, 2022
Nervous System Disease Trial run by the NIMH (Brain PET Imaging with 11C Rolipram, Whole Body PET Baseline with 11C Rolipram,
Completed
- Nervous System Disease
- Brain PET Imaging with 11C Rolipram
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 24, 2020
Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome
Withdrawn
- McCune-Albright Syndrome
- +3 more
- Hyperinsulinemic Euglycemic Clamp and 2H20
- +2 more
-
New Haven, ConnecticutYale New Haven Hospital
Aug 30, 2019
Inappropriate Secretion of FGF23 in Patients Followed in
Recruiting
- Hypophosphatemia Without Immediate Anteriority
- Unexplained Hypophosphatemia
- unexplained hypophoshatemia
-
Clermont-Ferrand, France
- +1 more
Mar 10, 2022
Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)
Recruiting
- Macrophage Activation Syndrome
- +6 more
-
Birmingham, Alabama
- +41 more
Jan 3, 2023
Meconium Aspiration Syndrome, Persistent Pulmonary Hypertension of Newborn Trial in Bhavnagar (Oral Sildenafil, Placebo
Completed
- Meconium Aspiration Syndrome
- Persistent Pulmonary Hypertension of Newborn
- Oral Sildenafil
- Placebo (distilled water)
-
Bhavnagar, Gujarat, IndiaNICU, Pediatrics department, SirTakhtasinhjiGH
May 15, 2022
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Myofascial Pain Syndromes, Neck Pain Trial in Istanbul (Group 1: Peppering, group 2: spin and wait, group 3: Peppering and spin
Recruiting
- Myofascial Pain Syndromes
- Neck Pain
- Group 1: Peppering
- +2 more
-
Istanbul, TurkeySultan 2. Abdulhamid Han Training and Research Hospital
Dec 30, 2022
Circulating Autotaxin in Patients With GNAS or PTH Abnormalities
Recruiting
- Fibrous Dysplasia
- +5 more
- blood sample
-
Bron, France
- +2 more
Mar 11, 2021
Trigger Point Pain, Myofascial Trial in Tokat (Taping)
Not yet recruiting
- Trigger Point Pain, Myofascial
- Taping
-
Tokat, Eyalet/Yerleşke, TurkeyTokat Gaziosmanpaşa University
Aug 24, 2023
Obstructive Sleep Apnea Trial in Vancouver, Montréal, Québec (Positive Airway Pressure (PAP), Mandibular Advancement Splints
Completed
- Obstructive Sleep Apnea
- Positive Airway Pressure (PAP)
- Mandibular Advancement Splints (MAS)
-
Vancouver, British Columbia, Canada
- +2 more
Nov 24, 2022
HIV, Mental Health Issue Trial in Coral Gables (Tell Me More ("Dime Mas"), Peer Ambassador Stories [Listen Miami ("Oye Miami")],
Not yet recruiting
- HIV
- Mental Health Issue
- Tell Me More ("Dime Mas")
- +2 more
-
Coral Gables, FloridaUniversity of Miami
Sep 26, 2023
Covid19, Pneumonia, Cytokine Release Syndrome Trial in Doha (Anakinra, Standard of Care)
Completed
- Covid19
- +4 more
- Anakinra
- Standard of Care
-
Doha, QatarHamad Medical Corporation
Aug 15, 2022
Mealtime Assessment Scale-p Adaptation and Validation
Recruiting
- Dysphagia
- MAS-p administration
-
Florence, ItalyIRCCS Fondazione Don Carlo Gnocchi Onlus
Oct 23, 2023
Fibrous Dysplasia Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (denosumab)
Recruiting
- Fibrous Dysplasia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 15, 2022
Stroke Trial in Peshawar (Virtual Reality Training)
Completed
- Stroke
- Virtual Reality Training
-
Peshawar, Khyber Pakhtunkhwa, PakistanHazrat Bilal
Oct 9, 2022
ADHD Trial in Cincinnati (mixed amphetamine salts-extended release (MAS-XR), Placebo)
Active, not recruiting
- Attention Deficit Hyperactivity Disorder
- mixed amphetamine salts-extended release (MAS-XR)
- Placebo
-
Cincinnati, OhioUniversity of Cincinnati, Department of Psychiatry and Behaviora
Feb 25, 2022
Fatty Liver Disease, Obesity, Liver Fat Trial in Istanbul (Diet, Cornus mas L.(Cornelian Cherry))
Completed
- Fatty Liver Disease
- +2 more
- Diet
- Cornus mas L.(Cornelian Cherry)
-
Istanbul, Avcılar, TurkeyIstanbul Gelisim University
Sep 16, 2022
Aftercare for Stroke: MAS-I -Cross Sectional Study of
Completed
- Ischemic Stroke
-
Berlin, GermanyCharité - Universitätsmedizin Berlin (Center for Stroke Research
Dec 15, 2021
Insulin Resistance, Obesity, PreDiabetes Trial in Istanbul (Cornelian Cherry (Cornus mas L.), Diet)
Completed
- Insulin Resistance
- +2 more
- Cornelian Cherry (Cornus mas L.)
- Diet
-
Istanbul, Maltepe, TurkeyMarmara University
Sep 27, 2022
Macrophage Activation Syndrome Trial in Birmingham (kineret, )
Active, not recruiting
- Macrophage Activation Syndrome
- kineret
- placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2021